Brainstorm strengthens executive team with key appointments in r&d and legal

Netta blondheim-shraga, phd appointed as vp r&dantal pearl-lendner, adv. appointed as chief legal counsel new york , may 12, 2022 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced two senior management appointments.

BCLI Ratings Summary

BCLI Quant Ranking